Induction of DT-diaphorase by D3T in Human Tumor Cells
Author Information
Author(s): GP Doherty, MK Leith, X Wang, TJ Curphey, A Begleiter
Primary Institution: University of Manitoba
Hypothesis
D3T analogues can increase DT-diaphorase activity in human tumor cells and enhance the anti-tumor activity of bioreductive agents.
Conclusion
D3T analogues significantly increased DT-diaphorase activity in 28 of 38 human tumor cell lines, enhancing the anti-tumor activity of agents like MMC and E09.
Supporting Evidence
- D3T significantly increased DT-diaphorase activity in 28 of 38 human tumor cell lines.
- The enhancement of anti-tumor activity paralleled the level of DT-diaphorase induction.
- D3T did not significantly increase DT-diaphorase activity in normal kidney cells.
Takeaway
D3T helps cancer cells fight better against certain treatments by boosting a helpful enzyme, but it doesn't harm normal cells much.
Methodology
Human tumor cell lines were treated with D3T analogues, and DT-diaphorase activity was measured to assess the enzyme's induction and its effect on cytotoxicity of bioreductive agents.
Limitations
The study did not explore the long-term effects of D3T on normal cells or the exact mechanisms of enzyme induction.
Participant Demographics
Human tumor cell lines from various tissue types were used.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website